Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Sell
33,345
-15,560
-32% -$344K 0.02% 513
2026
Q1
$715K Buy
48,905
+10,160
+26% +$149K 0.02% 509
2025
Q4
$490K Sell
38,745
-7,255
-16% -$107K 0.01% 602
2025
Q3
$707K Buy
+46,000
New +$741K 0.02% 506

Other funds holding RXO

Cary Street Partners's RXO Position: Q2 2026 in Review

Cary Street Partners reduced its RXO (RXO) stake by 32% in Q2 2026, selling an estimated $344K and leaving 33,345 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #513.

Cary Street Partners first reported a position in RXO in Q3 2025 and has held it in 4 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Cary Street Partners held 33,345 shares of RXO worth $920K as of Q2 2026.
  • Cary Street Partners sold 15,560 RXO shares in Q2 2026, an estimated $344K.
  • RXO made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #513 holding.
  • Cary Street Partners first reported a position in RXO in Q3 2025 and has held it in 4 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.